Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

ASP Isotopes (NASDAQ:ASPI) Stock Ticks Up Ahead of Citi Natural Resources Conference

ASP Isotopes is trading modestly higher today after announcing its upcoming participation in a major investor conference. Shares rose as much as 3.46% to $4.19 in pre-market trading, adding to a 5.59% decline in the prior regular session, though the stock remains well off …

Nitish Kishor | 06 August 2026

Evolus (NASDAQ:EOLS) Stock Climbs 6% After Q2 Revenue Growth and Raised Guidance

Evolus is trading higher in pre-market action following a second-quarter report that showed accelerating growth and improving profitability. Shares rose as much as 5.69% to $6.53 in pre-market trading, building on a modest 0.98% gain in the prior regular session.

Nitish Kishor | 06 August 2026

Charles River Laboratories (NYSE:CRL) Surges 10% on Q2 Beat and Raised Full-Year Guidance

Charles River Laboratories (NYSE:CRL) shares surged more than 10% following second-quarter results that beat estimates across nearly every major metric, with non-GAAP earnings per share of 3.02 dollars topping the 2.74 dollar consensus by more than 10% and revenue of 1.00 billion dollars beating …

Nitish Kishor | 05 August 2026

Penny Stock Jupiter Neurosciences (NASDAQ:JUNS) Falls Sharply Ahead of Reverse Stock Split

Jupiter Neurosciences (NASDAQ:JUNS) is a clinical-stage biopharmaceutical company headquartered in Jupiter, Florida, focused on developing innovative therapies for neurological and neurodegenerative disorders. The company's proprietary lead program, JOTROL, an enhanced-bioavailability resveratrol formulation, is currently in a Phase IIa clinical trial for Parkinson's disease, and …

Nitish Kishor | 05 August 2026

LeMaitre Vascular (NASDAQ:LMAT) Plunges 25% at Close on Earnings Miss and Cut Guidance

LeMaitre Vascular (NASDAQ:LMAT) is a Burlington, Massachusetts-based medical device company that develops, manufactures, and markets a diversified portfolio of disposable and implantable devices for the treatment of peripheral vascular disease. Founded in 1983 by pioneering vascular surgeon George D. LeMaitre, the company offers more …

Nitish Kishor | 05 August 2026

LivaNova (NASDAQ:LIVN) Falls 8% at Close Despite Beat-and-Raise Quarter

LivaNova (NASDAQ:LIVN) is a global medical technology company headquartered in London, United Kingdom, formed in 2015 through the merger of Sorin S.p.A. and Cyberonics, combining deep expertise in cardiovascular and neuromodulation therapies. The company operates through two core segments, Cardiopulmonary, which designs and manufactures …

Nitish Kishor | 05 August 2026

Why Did Medline (NASDAQ:MDLN) Stock Tumble Despite a Q2 Beat?

Medline (NASDAQ:MDLN) is the largest provider of medical-surgical products and supply chain solutions in the United States, serving hospitals, surgical centers, physician offices, post-acute care facilities, and nursing homes both domestically and internationally. Founded in 1966 and headquartered in Northfield, Illinois, the company operates …

Nitish Kishor | 05 August 2026

Perrigo (NYSE:PRGO) Surges 23% at Close on Earnings Beat and Raised Guidance

Perrigo (NYSE:PRGO) is a Dublin, Ireland-headquartered consumer self-care company founded in 1887, recognized as the largest store-brand over-the-counter provider in the United States and a top 10 OTC company in Europe. Operating through its Consumer Self-Care Americas and Consumer Self-Care International segments, the company …

Nitish Kishor | 05 August 2026

Twist Bioscience (NASDAQ:TWST) Closes Up Nearly 16% on Guidance Raise and Stock Offering

Twist Bioscience (NASDAQ:TWST) is a South San Francisco-based synthetic biology company founded in 2013 that has developed a proprietary silicon-based DNA synthesis platform, enabling high-throughput, cost-effective manufacturing of synthetic DNA at unprecedented precision and scale. The company offers a broad portfolio of products and …

Nitish Kishor | 05 August 2026

Tyra Biosciences (NASDAQ:TYRA) Sinks Nearly 21% at Close Despite Cash Position Strength

Tyra Biosciences (NASDAQ:TYRA) is a clinical-stage biotechnology company headquartered in Carlsbad, California, focused on developing next-generation therapies that target Fibroblast Growth Factor Receptor biology to overcome tumor resistance and improve patient outcomes. Its lead candidate, dabogratinib, TYRA-300, is a highly selective FGFR3 inhibitor in …

Nitish Kishor | 05 August 2026
Support

Hi! How can we help you today?

Loading…